Global Risperidone Market Insights, Forecast to 2029

Publisher Name :
Date: 10-Aug-2023
No. of pages: 105
Inquire Before Buying

The global Risperidone market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Risperidone is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Risperidone is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Risperidone is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key manufacturers of Risperidone include Janssen (Johnson & Johnson), Ajanta Pharma, Amneal Pharmaceuticals, Aurobindo Pharma, Hikma, Sandoz, Lannett, Tris Pharma and Apotex, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:

This report presents an overview of global market for Risperidone, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Risperidone, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Risperidone, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Risperidone sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Risperidone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Risperidone sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Janssen (Johnson & Johnson), Ajanta Pharma, Amneal Pharmaceuticals, Aurobindo Pharma, Hikma, Sandoz, Lannett, Tris Pharma and Apotex, etc.

By Company

- Janssen (Johnson & Johnson)

- Ajanta Pharma

- Amneal Pharmaceuticals

- Aurobindo Pharma

- Hikma

- Sandoz

- Lannett

- Tris Pharma

- Apotex

- Celltrion

- Dr. Reddy's Laboratories

- Torrent Pharmaceuticals

- Luye Pharma Group

Segment by Type

- Tablet

- Oral Solution

Segment by Application

- Schizophrenia

- Bipolar Disorder

Segment by Region

- US & Canada

- - U.S.

- - Canada

- China

- Asia (excluding China)

- - Japan

- - South Korea

- - China Taiwan

- Southeast Asia

- - India

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Middle East, Africa, Latin America

- - Brazil

- - Mexico

- - Turkey

- - Israel

- - GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Risperidone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Risperidone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: China by type, by application sales and revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Risperidone sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Global Risperidone Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Risperidone Product Introduction
1.2 Market by Type
1.2.1 Global Risperidone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tablet
1.2.3 Oral Solution
1.3 Market by Application
1.3.1 Global Risperidone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Schizophrenia
1.3.3 Bipolar Disorder
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Risperidone Sales Estimates and Forecasts 2018-2029
2.2 Global Risperidone Revenue by Region
2.2.1 Global Risperidone Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Risperidone Revenue by Region (2018-2023)
2.2.3 Global Risperidone Revenue by Region (2024-2029)
2.2.4 Global Risperidone Revenue Market Share by Region (2018-2029)
2.3 Global Risperidone Sales Estimates and Forecasts 2018-2029
2.4 Global Risperidone Sales by Region
2.4.1 Global Risperidone Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Risperidone Sales by Region (2018-2023)
2.4.3 Global Risperidone Sales by Region (2024-2029)
2.4.4 Global Risperidone Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Risperidone Sales by Manufacturers
3.1.1 Global Risperidone Sales by Manufacturers (2018-2023)
3.1.2 Global Risperidone Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Risperidone in 2022
3.2 Global Risperidone Revenue by Manufacturers
3.2.1 Global Risperidone Revenue by Manufacturers (2018-2023)
3.2.2 Global Risperidone Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Risperidone Revenue in 2022
3.3 Global Key Players of Risperidone, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Risperidone Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Risperidone, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Risperidone, Product Offered and Application
3.8 Global Key Manufacturers of Risperidone, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Risperidone Sales by Type
4.1.1 Global Risperidone Historical Sales by Type (2018-2023)
4.1.2 Global Risperidone Forecasted Sales by Type (2024-2029)
4.1.3 Global Risperidone Sales Market Share by Type (2018-2029)
4.2 Global Risperidone Revenue by Type
4.2.1 Global Risperidone Historical Revenue by Type (2018-2023)
4.2.2 Global Risperidone Forecasted Revenue by Type (2024-2029)
4.2.3 Global Risperidone Revenue Market Share by Type (2018-2029)
4.3 Global Risperidone Price by Type
4.3.1 Global Risperidone Price by Type (2018-2023)
4.3.2 Global Risperidone Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Risperidone Sales by Application
5.1.1 Global Risperidone Historical Sales by Application (2018-2023)
5.1.2 Global Risperidone Forecasted Sales by Application (2024-2029)
5.1.3 Global Risperidone Sales Market Share by Application (2018-2029)
5.2 Global Risperidone Revenue by Application
5.2.1 Global Risperidone Historical Revenue by Application (2018-2023)
5.2.2 Global Risperidone Forecasted Revenue by Application (2024-2029)
5.2.3 Global Risperidone Revenue Market Share by Application (2018-2029)
5.3 Global Risperidone Price by Application
5.3.1 Global Risperidone Price by Application (2018-2023)
5.3.2 Global Risperidone Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Risperidone Market Size by Type
6.1.1 US & Canada Risperidone Sales by Type (2018-2029)
6.1.2 US & Canada Risperidone Revenue by Type (2018-2029)
6.2 US & Canada Risperidone Market Size by Application
6.2.1 US & Canada Risperidone Sales by Application (2018-2029)
6.2.2 US & Canada Risperidone Revenue by Application (2018-2029)
6.3 US & Canada Risperidone Market Size by Country
6.3.1 US & Canada Risperidone Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Risperidone Sales by Country (2018-2029)
6.3.3 US & Canada Risperidone Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Risperidone Market Size by Type
7.1.1 Europe Risperidone Sales by Type (2018-2029)
7.1.2 Europe Risperidone Revenue by Type (2018-2029)
7.2 Europe Risperidone Market Size by Application
7.2.1 Europe Risperidone Sales by Application (2018-2029)
7.2.2 Europe Risperidone Revenue by Application (2018-2029)
7.3 Europe Risperidone Market Size by Country
7.3.1 Europe Risperidone Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Risperidone Sales by Country (2018-2029)
7.3.3 Europe Risperidone Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Risperidone Market Size
8.1.1 China Risperidone Sales (2018-2029)
8.1.2 China Risperidone Revenue (2018-2029)
8.2 China Risperidone Market Size by Application
8.2.1 China Risperidone Sales by Application (2018-2029)
8.2.2 China Risperidone Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Risperidone Market Size by Type
9.1.1 Asia Risperidone Sales by Type (2018-2029)
9.1.2 Asia Risperidone Revenue by Type (2018-2029)
9.2 Asia Risperidone Market Size by Application
9.2.1 Asia Risperidone Sales by Application (2018-2029)
9.2.2 Asia Risperidone Revenue by Application (2018-2029)
9.3 Asia Risperidone Sales by Region
9.3.1 Asia Risperidone Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Risperidone Revenue by Region (2018-2029)
9.3.3 Asia Risperidone Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Risperidone Market Size by Type
10.1.1 Middle East, Africa and Latin America Risperidone Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Risperidone Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Risperidone Market Size by Application
10.2.1 Middle East, Africa and Latin America Risperidone Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Risperidone Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Risperidone Sales by Country
10.3.1 Middle East, Africa and Latin America Risperidone Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Risperidone Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Risperidone Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Janssen (Johnson & Johnson)
11.1.1 Janssen (Johnson & Johnson) Company Information
11.1.2 Janssen (Johnson & Johnson) Overview
11.1.3 Janssen (Johnson & Johnson) Risperidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Janssen (Johnson & Johnson) Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Janssen (Johnson & Johnson) Recent Developments
11.2 Ajanta Pharma
11.2.1 Ajanta Pharma Company Information
11.2.2 Ajanta Pharma Overview
11.2.3 Ajanta Pharma Risperidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Ajanta Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ajanta Pharma Recent Developments
11.3 Amneal Pharmaceuticals
11.3.1 Amneal Pharmaceuticals Company Information
11.3.2 Amneal Pharmaceuticals Overview
11.3.3 Amneal Pharmaceuticals Risperidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Amneal Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Amneal Pharmaceuticals Recent Developments
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Company Information
11.4.2 Aurobindo Pharma Overview
11.4.3 Aurobindo Pharma Risperidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Aurobindo Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Aurobindo Pharma Recent Developments
11.5 Hikma
11.5.1 Hikma Company Information
11.5.2 Hikma Overview
11.5.3 Hikma Risperidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Hikma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hikma Recent Developments
11.6 Sandoz
11.6.1 Sandoz Company Information
11.6.2 Sandoz Overview
11.6.3 Sandoz Risperidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Sandoz Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sandoz Recent Developments
11.7 Lannett
11.7.1 Lannett Company Information
11.7.2 Lannett Overview
11.7.3 Lannett Risperidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Lannett Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lannett Recent Developments
11.8 Tris Pharma
11.8.1 Tris Pharma Company Information
11.8.2 Tris Pharma Overview
11.8.3 Tris Pharma Risperidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Tris Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Tris Pharma Recent Developments
11.9 Apotex
11.9.1 Apotex Company Information
11.9.2 Apotex Overview
11.9.3 Apotex Risperidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Apotex Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Apotex Recent Developments
11.10 Celltrion
11.10.1 Celltrion Company Information
11.10.2 Celltrion Overview
11.10.3 Celltrion Risperidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Celltrion Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Celltrion Recent Developments
11.11 Dr. Reddy's Laboratories
11.11.1 Dr. Reddy's Laboratories Company Information
11.11.2 Dr. Reddy's Laboratories Overview
11.11.3 Dr. Reddy's Laboratories Risperidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Dr. Reddy's Laboratories Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Dr. Reddy's Laboratories Recent Developments
11.12 Torrent Pharmaceuticals
11.12.1 Torrent Pharmaceuticals Company Information
11.12.2 Torrent Pharmaceuticals Overview
11.12.3 Torrent Pharmaceuticals Risperidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Torrent Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Torrent Pharmaceuticals Recent Developments
11.13 Luye Pharma Group
11.13.1 Luye Pharma Group Company Information
11.13.2 Luye Pharma Group Overview
11.13.3 Luye Pharma Group Risperidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Luye Pharma Group Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Luye Pharma Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Risperidone Industry Chain Analysis
12.2 Risperidone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Risperidone Production Mode & Process
12.4 Risperidone Sales and Marketing
12.4.1 Risperidone Sales Channels
12.4.2 Risperidone Distributors
12.5 Risperidone Customers
13 Market Dynamics
13.1 Risperidone Industry Trends
13.2 Risperidone Market Drivers
13.3 Risperidone Market Challenges
13.4 Risperidone Market Restraints
14 Key Findings in The Global Risperidone Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Risperidone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Oral Solution
Table 4. Global Risperidone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Risperidone Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Risperidone Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Risperidone Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Risperidone Revenue Market Share by Region (2018-2023)
Table 9. Global Risperidone Revenue Market Share by Region (2024-2029)
Table 10. Global Risperidone Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Risperidone Sales by Region (2018-2023) & (K Pcs)
Table 12. Global Risperidone Sales by Region (2024-2029) & (K Pcs)
Table 13. Global Risperidone Sales Market Share by Region (2018-2023)
Table 14. Global Risperidone Sales Market Share by Region (2024-2029)
Table 15. Global Risperidone Sales by Manufacturers (2018-2023) & (K Pcs)
Table 16. Global Risperidone Sales Share by Manufacturers (2018-2023)
Table 17. Global Risperidone Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Risperidone Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Risperidone, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Risperidone Price by Manufacturers 2018-2023 (USD/Pcs)
Table 21. Global Risperidone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Risperidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risperidone as of 2022)
Table 23. Global Key Manufacturers of Risperidone, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Risperidone, Product Offered and Application
Table 25. Global Key Manufacturers of Risperidone, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Risperidone Sales by Type (2018-2023) & (K Pcs)
Table 28. Global Risperidone Sales by Type (2024-2029) & (K Pcs)
Table 29. Global Risperidone Sales Share by Type (2018-2023)
Table 30. Global Risperidone Sales Share by Type (2024-2029)
Table 31. Global Risperidone Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Risperidone Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Risperidone Revenue Share by Type (2018-2023)
Table 34. Global Risperidone Revenue Share by Type (2024-2029)
Table 35. Risperidone Price by Type (2018-2023) & (USD/Pcs)
Table 36. Global Risperidone Price Forecast by Type (2024-2029) & (USD/Pcs)
Table 37. Global Risperidone Sales by Application (2018-2023) & (K Pcs)
Table 38. Global Risperidone Sales by Application (2024-2029) & (K Pcs)
Table 39. Global Risperidone Sales Share by Application (2018-2023)
Table 40. Global Risperidone Sales Share by Application (2024-2029)
Table 41. Global Risperidone Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Risperidone Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Risperidone Revenue Share by Application (2018-2023)
Table 44. Global Risperidone Revenue Share by Application (2024-2029)
Table 45. Risperidone Price by Application (2018-2023) & (USD/Pcs)
Table 46. Global Risperidone Price Forecast by Application (2024-2029) & (USD/Pcs)
Table 47. US & Canada Risperidone Sales by Type (2018-2023) & (K Pcs)
Table 48. US & Canada Risperidone Sales by Type (2024-2029) & (K Pcs)
Table 49. US & Canada Risperidone Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Risperidone Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Risperidone Sales by Application (2018-2023) & (K Pcs)
Table 52. US & Canada Risperidone Sales by Application (2024-2029) & (K Pcs)
Table 53. US & Canada Risperidone Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Risperidone Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Risperidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Risperidone Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Risperidone Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Risperidone Sales by Country (2018-2023) & (K Pcs)
Table 59. US & Canada Risperidone Sales by Country (2024-2029) & (K Pcs)
Table 60. Europe Risperidone Sales by Type (2018-2023) & (K Pcs)
Table 61. Europe Risperidone Sales by Type (2024-2029) & (K Pcs)
Table 62. Europe Risperidone Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Risperidone Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Risperidone Sales by Application (2018-2023) & (K Pcs)
Table 65. Europe Risperidone Sales by Application (2024-2029) & (K Pcs)
Table 66. Europe Risperidone Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Risperidone Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Risperidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Risperidone Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Risperidone Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Risperidone Sales by Country (2018-2023) & (K Pcs)
Table 72. Europe Risperidone Sales by Country (2024-2029) & (K Pcs)
Table 73. China Risperidone Sales by Type (2018-2023) & (K Pcs)
Table 74. China Risperidone Sales by Type (2024-2029) & (K Pcs)
Table 75. China Risperidone Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Risperidone Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Risperidone Sales by Application (2018-2023) & (K Pcs)
Table 78. China Risperidone Sales by Application (2024-2029) & (K Pcs)
Table 79. China Risperidone Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Risperidone Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Risperidone Sales by Type (2018-2023) & (K Pcs)
Table 82. Asia Risperidone Sales by Type (2024-2029) & (K Pcs)
Table 83. Asia Risperidone Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Risperidone Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Risperidone Sales by Application (2018-2023) & (K Pcs)
Table 86. Asia Risperidone Sales by Application (2024-2029) & (K Pcs)
Table 87. Asia Risperidone Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Risperidone Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Risperidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Risperidone Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Risperidone Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Risperidone Sales by Region (2018-2023) & (K Pcs)
Table 93. Asia Risperidone Sales by Region (2024-2029) & (K Pcs)
Table 94. Middle East, Africa and Latin America Risperidone Sales by Type (2018-2023) & (K Pcs)
Table 95. Middle East, Africa and Latin America Risperidone Sales by Type (2024-2029) & (K Pcs)
Table 96. Middle East, Africa and Latin America Risperidone Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Risperidone Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Risperidone Sales by Application (2018-2023) & (K Pcs)
Table 99. Middle East, Africa and Latin America Risperidone Sales by Application (2024-2029) & (K Pcs)
Table 100. Middle East, Africa and Latin America Risperidone Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Risperidone Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Risperidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Risperidone Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Risperidone Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Risperidone Sales by Country (2018-2023) & (K Pcs)
Table 106. Middle East, Africa and Latin America Risperidone Sales by Country (2024-2029) & (K Pcs)
Table 107. Janssen (Johnson & Johnson) Company Information
Table 108. Janssen (Johnson & Johnson) Description and Major Businesses
Table 109. Janssen (Johnson & Johnson) Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 110. Janssen (Johnson & Johnson) Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Janssen (Johnson & Johnson) Recent Developments
Table 112. Ajanta Pharma Company Information
Table 113. Ajanta Pharma Description and Major Businesses
Table 114. Ajanta Pharma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 115. Ajanta Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Ajanta Pharma Recent Developments
Table 117. Amneal Pharmaceuticals Company Information
Table 118. Amneal Pharmaceuticals Description and Major Businesses
Table 119. Amneal Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 120. Amneal Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Amneal Pharmaceuticals Recent Developments
Table 122. Aurobindo Pharma Company Information
Table 123. Aurobindo Pharma Description and Major Businesses
Table 124. Aurobindo Pharma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 125. Aurobindo Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Aurobindo Pharma Recent Developments
Table 127. Hikma Company Information
Table 128. Hikma Description and Major Businesses
Table 129. Hikma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 130. Hikma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Hikma Recent Developments
Table 132. Sandoz Company Information
Table 133. Sandoz Description and Major Businesses
Table 134. Sandoz Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 135. Sandoz Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Sandoz Recent Developments
Table 137. Lannett Company Information
Table 138. Lannett Description and Major Businesses
Table 139. Lannett Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 140. Lannett Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Lannett Recent Developments
Table 142. Tris Pharma Company Information
Table 143. Tris Pharma Description and Major Businesses
Table 144. Tris Pharma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 145. Tris Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Tris Pharma Recent Developments
Table 147. Apotex Company Information
Table 148. Apotex Description and Major Businesses
Table 149. Apotex Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 150. Apotex Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Apotex Recent Developments
Table 152. Celltrion Company Information
Table 153. Celltrion Description and Major Businesses
Table 154. Celltrion Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 155. Celltrion Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Celltrion Recent Developments
Table 157. Dr. Reddy's Laboratories Company Information
Table 158. Dr. Reddy's Laboratories Description and Major Businesses
Table 159. Dr. Reddy's Laboratories Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 160. Dr. Reddy's Laboratories Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Dr. Reddy's Laboratories Recent Developments
Table 162. Torrent Pharmaceuticals Company Information
Table 163. Torrent Pharmaceuticals Description and Major Businesses
Table 164. Torrent Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 165. Torrent Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Torrent Pharmaceuticals Recent Developments
Table 167. Luye Pharma Group Company Information
Table 168. Luye Pharma Group Description and Major Businesses
Table 169. Luye Pharma Group Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 170. Luye Pharma Group Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Luye Pharma Group Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Risperidone Distributors List
Table 175. Risperidone Customers List
Table 176. Risperidone Market Trends
Table 177. Risperidone Market Drivers
Table 178. Risperidone Market Challenges
Table 179. Risperidone Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Risperidone Product Picture
Figure 2. Global Risperidone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Risperidone Market Share by Type in 2022 & 2029
Figure 4. Tablet Product Picture
Figure 5. Oral Solution Product Picture
Figure 6. Global Risperidone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Risperidone Market Share by Application in 2022 & 2029
Figure 8. Schizophrenia
Figure 9. Bipolar Disorder
Figure 10. Risperidone Report Years Considered
Figure 11. Global Risperidone Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Risperidone Revenue 2018-2029 (US$ Million)
Figure 13. Global Risperidone Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Risperidone Revenue Market Share by Region (2018-2029)
Figure 15. Global Risperidone Sales 2018-2029 ((K Pcs)
Figure 16. Global Risperidone Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Risperidone Sales YoY (2018-2029) & (K Pcs)
Figure 18. US & Canada Risperidone Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Risperidone Sales YoY (2018-2029) & (K Pcs)
Figure 20. Europe Risperidone Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Risperidone Sales YoY (2018-2029) & (K Pcs)
Figure 22. China Risperidone Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Risperidone Sales YoY (2018-2029) & (K Pcs)
Figure 24. Asia (excluding China) Risperidone Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Risperidone Sales YoY (2018-2029) & (K Pcs)
Figure 26. Middle East, Africa and Latin America Risperidone Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Risperidone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Risperidone in the World: Market Share by Risperidone Revenue in 2022
Figure 29. Global Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Risperidone Sales Market Share by Type (2018-2029)
Figure 31. Global Risperidone Revenue Market Share by Type (2018-2029)
Figure 32. Global Risperidone Sales Market Share by Application (2018-2029)
Figure 33. Global Risperidone Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Risperidone Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Risperidone Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Risperidone Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Risperidone Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Risperidone Revenue Share by Country (2018-2029)
Figure 39. US & Canada Risperidone Sales Share by Country (2018-2029)
Figure 40. U.S. Risperidone Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Risperidone Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Risperidone Sales Market Share by Type (2018-2029)
Figure 43. Europe Risperidone Revenue Market Share by Type (2018-2029)
Figure 44. Europe Risperidone Sales Market Share by Application (2018-2029)
Figure 45. Europe Risperidone Revenue Market Share by Application (2018-2029)
Figure 46. Europe Risperidone Revenue Share by Country (2018-2029)
Figure 47. Europe Risperidone Sales Share by Country (2018-2029)
Figure 48. Germany Risperidone Revenue (2018-2029) & (US$ Million)
Figure 49. France Risperidone Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Risperidone Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Risperidone Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Risperidone Revenue (2018-2029) & (US$ Million)
Figure 53. China Risperidone Sales Market Share by Type (2018-2029)
Figure 54. China Risperidone Revenue Market Share by Type (2018-2029)
Figure 55. China Risperidone Sales Market Share by Application (2018-2029)
Figure 56. China Risperidone Revenue Market Share by Application (2018-2029)
Figure 57. Asia Risperidone Sales Market Share by Type (2018-2029)
Figure 58. Asia Risperidone Revenue Market Share by Type (2018-2029)
Figure 59. Asia Risperidone Sales Market Share by Application (2018-2029)
Figure 60. Asia Risperidone Revenue Market Share by Application (2018-2029)
Figure 61. Asia Risperidone Revenue Share by
  • Global Divalproex Sodium Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81
    Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......
  • Global Divalproex Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......
  • Global Quetiapine Fumarate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......
  • Global Clozapine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Trazodone Hydrochloride (API) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......
  • Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93
    According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......
  • Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......
  • Global Risperidone Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......
  • Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028
    Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101
    Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs